MIAMI & LONDON--(BUSINESS WIRE)--Bio-Tissue, Inc., a business unit of TissueTech, Inc., is pleased to
announce a strategic agreement with Scope, a fast-growing eye care
company offering innovative ophthalmic products in the UK and Ireland.
The companies will work together to bring Bio-Tissue’s PROKERA® biologic
corneal bandage devices to the UK and Irish eye care professionals
market.
“Our collaboration with Scope will help us expand our distribution and
bring PROKERA to eye doctors in the UK and Irish markets,” said Thomas
G. Daniells, Chief Commercial Officer, Bio-Tissue. “Scope is a leading
supplier of ocular surface disease therapies in these countries, and as
such is an ideal partner to offer PROKERA to eye care professionals and
to bring our regenerative healing technology to their patients across
the entire corneal disease spectrum.”
Eye doctors around the world use PROKERA biologic corneal bandage
devices for use in healing and treating corneal involved dry eye,
keratitis, recurrent corneal erosions and other ocular surface diseases.
The PROKERA products – PROKERA Slim, the original PROKERA, PROKERA Plus
and PROKERA Clear – are the only therapeutic devices cleared by the U.S.
Food and Drug Administration (FDA) that simultaneously reduce
inflammation and promote regenerative healing of the ocular surface.
Scope has a strong Irish heritage of over 80 years in the healthcare
sector. The company, which is currently managed by John & Tom Freyne,
helps bring some of the most innovative, evidence based eye care
solutions to the UK and Irish markets.
Tom Freyne, Director at Scope said, “Scope is delighted to be a
strategic partner of Bio-Tissue and to be launching PROKERA to the UK
and Irish markets. At Scope, our philosophy is to deliver innovative
products that help improve patient outcomes. The launch of PROKERA in
the UK and Ireland will help to reinforce this philosophy by supporting
healthcare professionals in treating their patients more effectively and
providing them with superior outcomes. We look forward to working with
the team at Bio-Tissue and growing the PROKERA brand in the UK and
Ireland.”
About Bio-Tissue
Bio-Tissue ( ),
a business unit of TissueTech, Inc., develops and markets regenerative
therapies that allow eye care professionals to advance the standard of
care for treating the ocular surface. Its core products include
cryopreserved amniotic membrane and umbilical cord-based tissue with
innate therapeutic actions scientifically proven to heal the ocular
surface. The Company’s proprietary CryoTek® preservation
method ensures the tissue retains its biologic activity and healing
components. To date, more than 300,000 allografts have been transplanted
collectively by Bio-Tissue and sister company Amniox Medical (TissueTech
business units).
About Scope
Scope ( )
is an innovative and fast-growing eye care company offering dry eye and
blepharitis products in the UK and Ireland. The company maintains a
major focus on training, customer service, innovation and relationships
with key opinion leaders. The Scope range of products include TearLab®,
the first quantitative diagnostic device for Dry Eye Disease (DED), the
well-known HYLO® range of preservative-free lubricants for all
severities of DED, and BlephEx™, unique clinician treatment for
blepharitis helping clinicians extend their in-clinic offering, and
PROKERA, a biologic corneal bandage for the treatment of ocular surface
diseases.
Bio-TissueSilvana Guerci-Lena, 508-808-8993sguercilena@biotissue.comorScopeLiadain
Murphy, 353 87 9650653liadainmurphy@scopeophthalmics.com
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.